HIRSCHMAN ORIN 13D and 13G filings for Cognition Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 7:01 pm Sale |
2024-01-30 | 13G | Cognition Therapeutics, Inc. CGTX |
HIRSCHMAN ORIN | 1,448,270 4.800% |
-589,583 (-28.93%) |
Filing |
| 2023-02-15 07:02 am Unchanged |
2022-12-31 | 13G | Cognition Therapeutics, Inc. CGTX |
HIRSCHMAN ORIN | 2,037,853 7.000% |
0 (Unchanged) |
Filing |
| 2022-11-18 07:21 am Purchase |
2022-11-10 | 13G | Cognition Therapeutics, Inc. CGTX |
HIRSCHMAN ORIN | 2,037,853 7.000% |
2,037,853 (New Position) |
Filing |